<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02357862</url>
  </required_header>
  <id_info>
    <org_study_id>MVR_TV</org_study_id>
    <nct_id>NCT02357862</nct_id>
  </id_info>
  <brief_title>Changes in the Tricuspid Valve Complex Induced by Mitral Valve Annuloplasty</brief_title>
  <official_title>Impact of Mitral Valve Annuloplasty on the Tricuspid Valve Complex</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the impact of isolated mitral valve annuloplasty on
      the geometry and the function of the tricuspid valve complex.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed pathogenesis of functional tricuspid regurgitation (TR) in mitral valve disease
      seems incomplete. Because both atrioventricular valves are closely connected to each other by
      means of the cardiac fibrous skeleton, the geometry of the tricuspid valve is likely to be
      distorted after ring-annuloplasty of the mitral valve. This could lead to the development of
      functional TR, or to an increase in TR severity. To test this hypothesis, a prospective study
      will be started in patients undergoing isolated mitral valve annuloplasty.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative geometric changes in tricuspid valve annulus (TA)</measure>
    <time_frame>day 0</time_frame>
    <description>Measurement of changes in 3D descriptors of the TA (e.g. changes from baseline in the TA area of the best-fit plane in cm^2, and changes from baseline in the height of each TA point to the TA best-fit plane in mm)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">22</enrollment>
  <condition>Tricuspid (Valve); Deformity</condition>
  <arm_group>
    <arm_group_label>Mitral Valve Annuloplasty</arm_group_label>
    <description>All eligible patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mitral Valve Annuloplasty</intervention_name>
    <description>Mitral valve annuloplasty by a rigid mitral ring, a semi-rigid ring, or a fully flexible band, at the surgeon's discretion</description>
    <arm_group_label>Mitral Valve Annuloplasty</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing minimally invasive, isolated mitral valve annuloplasty in the
        University Hospitals Leuven
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients 18 years of age or older undergoing minimally invasive, isolated mitral
             valve annuloplasty

        Exclusion Criteria:

          -  concomitant tricuspid valve surgery

          -  atrial fibrillation at the moment of surgery

          -  poor echocardiographic windows
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Werner Budts, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven - University of Leuven, Department of Cardiovascular Sciences, Division of Cardiology; University Hospitals Leuven, Department of Cardiology</affiliation>
  </overall_official>
  <removed_countries>
    <country>Belgium</country>
  </removed_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2015</study_first_submitted>
  <study_first_submitted_qc>February 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2015</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Heart Valve Diseases</keyword>
  <keyword>Mitral Valve Annuloplasty</keyword>
  <keyword>Tricuspid Valve Insufficiency</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

